EUVIMEDScopri EUVIMED
FallberichtOpen access · CC BY 4.0

Identification of Compound Heterozygous EVC2 Gene Variants in Two Mexican Families with Ellis–van Creveld Syndrome

Nancy Negrete-Torres, María Del Carmen Chima-Galán, Ernesto Antonio Sierra-López, Janet Sánchez-Ramos, Isela Álvarez-González iD, Julia Reyes-Reali, María Isabel Mendoza-Ramos, Efraín Garrido-Guerrero, Dante Amato, Claudia Fabiola Méndez-Catalá iD, Glustein Pozo-Molina iD, Adolfo René Méndez-Cruz

Genes · 2023

DOI: 10.3390/genes14040887 ↗

At a glance

Fallbericht in Genes, 2023. Written by Nancy Negrete-Torres and 11 co-authors. Institution: Laboratorio de Genética y Oncología Molecular, Laboratorio 5, Edificio A4, Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, Univ…. Major MEDLINE topics: Membrane Proteins, Ellis-Van Creveld Syndrome. Cited 2 times so far (Crossref); 58 references. The full text is freely available (open access, CC BY 4.0). Funded by: Universidad Nacional Autonoma de Mexico.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Ellis–van Creveld syndrome (EvCS) is an autosomal recessive ciliopathy with a disproportionate short stature, polydactyly, dystrophic nails, oral defects, and cardiac anomalies. It is caused by pathogenic variants in the EVC or EVC2 genes. To obtain further insight into the genetics of EvCS, we identified the genetic defect for the EVC2 gene in two Mexican patients.

Methods

Two Mexican families were enrolled in this study. Exome sequencing was applied in the probands to screen potential genetic variant(s), and then Sanger sequencing was used to identify the variant in the parents. Finally, a prediction of the three-dimensional structure of the mutant proteins was made.

Results

One patient has a compound heterozygous EVC2 mutation: a novel heterozygous variant c.519_519 + 1delinsT inherited from her mother, and a heterozygous variant c.2161delC (p.L721fs) inherited from her father. The second patient has a previously reported compound heterozygous EVC2 mutation: nonsense mutation c.645G > A (p.W215*) in exon 5 inherited from her mother, and c.273dup (p.K92fs) in exon 2 inherited from her father. In both cases, the diagnostic was Ellis–van Creveld syndrome. Three-dimensional modeling of the EVC2 protein showed that truncated proteins are produced in both patients due to the generation of premature stop codons.

Conclusion

The identified novel heterozygous EVC2 variants, c.2161delC and c.519_519 + 1delinsT, were responsible for the Ellis–van Creveld syndrome in one of the Mexican patients. In the second Mexican patient, we identified a compound heterozygous variant, c.645G > A and c.273dup, responsible for EvCS. The findings in this study extend the EVC2 mutation spectrum and may provide new insights into the EVC2 causation and diagnosis with implications for genetic counseling and clinical management.

Subjects

MeSH terms (MEDLINE)

Membrane ProteinsEllis-Van Creveld SyndromeHumansFemaleIntercellular Signaling Peptides and ProteinsPedigreeMutationCodon, Nonsense

Author keywords

EVC2 geneEllis–van Creveld syndromeMexican patientsciliopathieswhole exome sequencing

Substances

Membrane ProteinsIntercellular Signaling Peptides and ProteinsCodon, Nonsense

Authors and institutions

  • Laboratorio de Genética y Oncología Molecular, Laboratorio 5, Edificio A4, Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
  • Laboratorio de Genética, Escuela Nacional de Ciencias Biológicas Zacatenco, Instituto Politécnico Nacional, Ciudad de México 07738, Mexico.
  • Centro Médico Nacional "20 de Noviembre", ISSSTE, Ciudad de México 03229, Mexico.
  • Laboratorio de Inmunología, Unidad de Morfofisiología y Función, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
  • Departamento de Genética y Biología Molecular, CINVESTAV-IPN, Ciudad de México 07360, Mexico.
  • División de Investigación y Posgrado, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.

ORCID profiles: Isela Álvarez-González, Claudia Fabiola Méndez-Catalá, Glustein Pozo-Molina

Funding

  • Universidad Nacional Autonoma de Mexico

Cite

APA

Negrete-Torres, N., Chima-Galán, M. D. C., Sierra-López, E. A., Sánchez-Ramos, J., Álvarez-González, I., Reyes-Reali, J., Mendoza-Ramos, M. I., Garrido-Guerrero, E., Amato, D., Méndez-Catalá, C. F., Pozo-Molina, G., & Méndez-Cruz, A. R. (2023). Identification of Compound Heterozygous EVC2 Gene Variants in Two Mexican Families with Ellis–van Creveld Syndrome. Genes. https://doi.org/10.3390/genes14040887

Vancouver

Negrete-Torres N, Chima-Galán MDC, Sierra-López EA, Sánchez-Ramos J, Álvarez-González I, Reyes-Reali J, et al. Identification of Compound Heterozygous EVC2 Gene Variants in Two Mexican Families with Ellis–van Creveld Syndrome. Genes. 2023. doi:10.3390/genes14040887

BibTeX
@article{NegreteTorres2023,
  author = {Negrete-Torres, Nancy and Chima-Galán, María Del Carmen and Sierra-López, Ernesto Antonio and Sánchez-Ramos, Janet and Álvarez-González, Isela and Reyes-Reali, Julia and Mendoza-Ramos, María Isabel and Garrido-Guerrero, Efraín and Amato, Dante and Méndez-Catalá, Claudia Fabiola and Pozo-Molina, Glustein and Méndez-Cruz, Adolfo René},
  title = {Identification of Compound Heterozygous EVC2 Gene Variants in Two Mexican Families with Ellis–van Creveld Syndrome},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14040887}
}
Start for free →